Back to News
Market Impact: 0.3
AI-Discovered Drug Reverses Aging Markers in Study, Biotech Says
Source: Bloomberg
Artificial IntelligenceHealthcare & BiotechTechnology & Innovation
An AI-developed experimental lung disease drug showed promising evidence of reversing biological markers of aging, according to its developer. The findings could broaden the treatment's potential beyond its initial lung-disease indication, although the article provides no clinical efficacy figures, regulatory milestones, or commercial timeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
More News
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- PG&E’s CEO says AI is ‘the best thing that could’ve ever happened to the grid’
- The mobile ambitions of SpaceX see telecom stocks get hit again. What the latest developments mean.
- Wake up! The long bond’s up two points!
- US tech stocks tumble as investors fret over AI spending
- Mark Zuckerberg owns 13% of Meta but controls 61% of its votes. California’s wealth tax would bill him on the 13%